Journal
COMPOSITES PART B-ENGINEERING
Volume 123, Issue -, Pages 279-291Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.compositesb.2017.05.011
Keywords
3D bioprinting; Bioinks; Vascular; Vascularized tissue; Soft materials
Funding
- National Science Foundation [1634858]
- Texas AM [292106]
- TEES [225260]
- AmCare Genomics Laboratory [600288]
- Directorate For Engineering
- Div Of Civil, Mechanical, & Manufact Inn [1634858] Funding Source: National Science Foundation
Ask authors/readers for more resources
Vascularization is a leading limitation for the clinical application of in vitro engineered tissue constructs because of the insufficient blood supply in the initial phase after implantation. In spite of decades of progress in the tissue engineering field, vascularization is a major issue that remains unsolved. The advent of 3D bioprinting technology provides a powerful means to resolve the vascularization problem for its advanced time and spatial control, capacity to be changed in size or scale, as well as reproducibility, compared to traditional fabrication processes. This paper aims to review the recent progress of 3D bioprinting technology in the fabrication of blood vessel, vasculature and vascularized tissue constructs. 3D bioprinting methods and the engineered bioinks for vascular-structure constructions are discussed and compared, followed by a concise discussion of limitations and challenges encountered towards current 3D bioprinting of vascularized tissue. Finally, future research directions on the development of 3D bioprinting processes and bioinks for natural tissue constructions are also discussed. (C) 2017 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available